Skip to main content
. 2022 Dec 2;10(2):e200072. doi: 10.1212/NXI.0000000000200072

Figure 3. Levels of Nucleotide-Binding Oligomerization Domain–Containing Protein 2 (NOD2) and Osteopontin (Spp1) Across Diagnostic Groups (Controls, n = 102; ALS, n = 123; AD, n = 30; and FTD, n = 28).

Figure 3

Group differences between serum biomarker raw levels of (A) NOD2 and (B) Spp1. Error bars represent the 10th to 90th percentile range of data, and circles represent outliers. *<0.001. AD = Alzheimer disease; ALS = amyotrophic lateral sclerosis; FTD = frontotemporal dementia; HC = healthy control.